Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_888_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
34 Мб
Скачать
9 Patient Comorbidities Complicating aHernia Repair
111
showing a signicant increase in postoperative wound infection in smokers com­pared to nonsmokers. In addition to the above operative complications, multiple studies have demonstrated smoking to be a signicant predictor of perioperative respiratory complications in the setting of all surgery [5] as well as hernia repair surgery specically [6]. Smoking has also been shown to increase the risk for readmission following hernia repair in numerous studies [7, 8]. Finally, in addi­tion to the increased risk of surgical site occurrence and perioperative complica­tions, smoking has been shown to be a direct predictor of recurrence following hernia repair [9, 10].
As previously noted, smoking presents as a unique preoperative risk factor that is readily intervened upon before surgery. These interventions may include both counseling and nicotine replacement therapy, which has been shown to be effective in patients undergoing hernia repair. While some of the detrimental physiologic activity of smoking may be attributable to nicotine, smoking cessation strategies that utilize nicotine patches have been shown in prospective randomized controlled trials to have an overall benet in the reduction of postoperative complications including wound infection, dehiscence, and readmission [11].
With this evidence in mind, our recommendation in elective hernia repair is for the mandatory cessation of smoking preoperatively for at least 4 weeks [10]. Compliance toward smoking cessation can be evaluated using the cotinine assay, which has a high diagnostic performance in determining whether patients are cur­rently smoking and are expected to have a high risk of perioperative complica­tions. While we recommend both counseling and nicotine replacement therapy as strategies to achieve smoking cessation, it should be noted that nicotine replace­ment will yield a positive cotinine test; thus, this test should be ruled out in deter­mining compliance. Thus, if the surgeon suspects noncompliance, obtaining anabasine or nornicotine levels (indicates tobacco use irrespective of nicotine replacement therapy) may be warranted. To decrease morbidity, we recommend that any patient found to be non-compliant should be rescheduled for surgery particularly in the setting of complex hernia repair and abdominal wall recon­struction. When dealing with smaller noncomplex hernias, smoking might not necessarily result in signicant wound morbidity; however, uniform smoking ces­sation is our rule.
Obesity
Obesity represents a signicant risk factor in hernia repair during both the periop­erative and longitudinal periods. The relationship between obesity, metabolic syn­drome, and cardiopulmonary comorbidities predisposes patients to complications during the physiologic demands of surgery. This relationship was demonstrated in a retrospective analysis of 78,348 patients who underwent ventral hernia repair in the United States between 2004 and 2008.This analysis showed an increased risk of serious pulmonary complications, including pneumonia, respiratory distress, and pulmonary embolism, as well as signicantly longer hospital admissions in
112
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
D. T. K. Huynh and O. M. Ghanem
patients with obesity [12]. This evidence has been correlated in multiple studies that also identify the relationship between obesity and complications in the imme­diate postoperative period as well as the role of obesity as a risk factor for recur­rence [13, 14].
In the setting of open ventral hernia repair, patients with a BMI40 have been shown to be signicantly more likely to undergo a subsequent operation to repair a recurrence [15]. One of the primary reasons for this increased risk for recurrence lies in the predisposition of obese patients toward surgical site occurrences [16]. As such, minimally invasive approaches have been postulated to decrease this risk of surgical site occurrence and thereby decrease the chance of recurrence. However, obesity presents a unique challenge in minimally invasive approaches as thick abdominal walls and large amounts of visceral fat increase the technical difculty of these repairs. Ultimately, the evidence shows similar ndings between laparo­scopic approaches and open ventral hernia repair. A retrospective study of 901 patients who underwent laparoscopic ventral hernia repair also showed that patients with a BMI40 are at an increased risk for recurrence following hernia repair [17]. Following this evidence, we currently recommend that patients whose BMI falls into this range should not undergo open or laparoscopic elective hernia repair until their weight has been optimized.
Rapid developments in the eld of hernia repair and bariatrics create an ever­changing landscape in managing these patients. Guidelines for optimal manage­ment will change as more ventral hernia repairs and abdominal wall reconstructions employ minimally invasive approaches with mesh in the retrorectus and preperito­neal positions. Guidelines will also change with new bariatric solutions, such as balloon occlusion and endoscopic gastric sleeve. In light of this, our current recom­mendations for managing hernia in obese patients are as follows.
Preoperative weight loss begins with medical weight loss. A well-established protocol for patients with ventral hernias and associated obesity was described by Rosen etal. [18] The protocol utilizes a protein-sparing modied fast in collabora­tion with a medical weight loss specialist. Using this technique, the authors were able to reduce the BMI of a group of 25 patients from an average of 49 to 40 kg/m over an average period of 17months prior to undergoing complex abdominal wall reconstruction. In addition, 88% of the patients were able to maintain this reduc­tion in weight for up to 18 months postoperatively. If this initial medical and behavioral therapy fails, we recommend bariatric surgical intervention. In patients with concomitant morbid obesity and ventral hernia who have failed medical man­agement, we recommend a minimally invasive weight loss operation followed by repair of the hernia. Repair of the hernia should be timed to occur during the pla­teau in the weight loss curve after bariatric surgery, typically at approximately 12–18months postoperatively. Patients for whom a minimally invasive bariatric procedure is not an option present a more complicated clinical decision. In cases that necessitate an open weight loss operation, the surgeon must evaluate the risks and benets of simultaneously repairing the hernia in order to close the abdominal fascia without tension.
2
9 Patient Comorbidities Complicating aHernia Repair
113
Diabetes
Hyperglycemia has profound effects on wound healing through both immunomodu­latory and vasculopathic mechanisms. Due to a blunted inammatory response, patients with diabetes are at risk for delayed wound healing. Additionally, damage to the microvasculature can lead to relative ischemia, further decreasing the patient’s capacity to recover following surgery. For patients undergoing inguinal hernia repair, diabetes has been shown to increase the risk of complications in the intraop­erative and immediate postoperative period (<30days). This increased risk of com­plications included infections, bleeding complications, and supercial wound dehiscence [19]. Regarding complex hernia repairs, insulin-dependent patients and patients with a blood glucose of >140mg/dL were found to have a lengthened time to their rst meal following surgery as well as an increased length of stay and increased cost of hospitalization [20].
As described in the studies above, a patient’s current glycemic status plays a critical role in their ability to heal and ght infection. A study conducted between 2000 and 2003 showed a signicant reduction in surgical site infection in patients with a hemoglobin A1c of less than 7% in the setting of all non-cardiac surgery. This generalized nding has been corroborated in hernia repair as well; Petro et al. showed that a diagnosis of diabetes is a signicant predictor of surgical site occur­rence including surgical site infection [21]. Following from this association in regard to surgical site occurrence, diabetes has also been linked to an increased risk of recurrence in umbilical hernia repair [22].
Considering this evidence, our recommendations align with the expert consensus on ventral hernia management [23]. Patients with a hemoglobin A1c of greater than 8% should not undergo elective hernia repair. Patients with a hemoglobin A1c between 6.5 and 8% must rst be optimized through either medical or surgical means. Once long-term glycemic control has been achieved, we recommend a peri­operative blood glucose level of approximately 140 mg/dL, which prevents the aforementioned consequences of hyperglycemia while also preventing the risks associated with hypoglycemia in the operative setting.
Nutritional Assessment andSupplements
Nutritional status is of critical importance when considering a patient for surgery. Failing to optimize a patient’s nutritional status preoperatively increases the risks of morbidity, mortality, and poor outcomes [24, 25]. A well-studied method of assess­ing nutritional status in the surgical literature uses serum chemistries, such as albu­min, with low levels of albumin predicting poor postoperative outcomes [26, 27]. However, recent evidence offers imaging techniques as an alternate modality for assessing a patient’s preoperative nutritional status. Using cross-sectional imaging, a patient’s sarcopenia, and thereby their nutritional status, can be evaluated by com­paring the ratio of lean body mass to lipid content [28].
114
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
D. T. K. Huynh and O. M. Ghanem
Several nutrients have been evaluated in the literature and have been demon­strated to have a signicant clinical impact when given prior to surgery. Arginine is one such nutrient and has been shown to improve wound healing, augment the tis­sue inammatory response, and prevent ischemia by promoting vasodilation through local increases in NO [2931]. While the specic benets of preoperative arginine administration have not been shown in hernia surgery specically, they have been described in the colorectal literature and showed a decrease in the number of read­missions and hospital days [32].
In addition to individual agents, the repletion of certain combinations of nutri­ents has been shown to decrease the rate of perioperative complications. One well-studied regimen is the “metabolic modulating formula” described by Braga etal. [33], which included omega-3 fatty acids, docosahexaenoic acid, and eicosa­pentaenoic acid. When preoperatively optimized using these nutrients, patients were demonstrated to have reductions in infection, length of stay, and hospital cost [34]. In addition to optimizing patients with these nutrients, the patients can also be preoperatively loaded with carbohydrates to maximize glycogen stores during surgery [35].
We nd that while nutrition is of critical importance, it is often overlooked dur­ing the preoperative planning period. There remains a signicant lack of evidence­based recommendations on the subject, especially as it pertains to specic areas of surgery such as hernia. To date, there is a marked absence of evidence guiding nutritional management in abdominal wall reconstruction. In this setting, we apply the generalized data discussed above and administer the Impact© Nutritional Supplement three times daily for the 5days leading up to surgery to replete the vali­dated nutrients in the metabolic modulating formula.
Other Comorbid Conditions
The NSQIP surgical risk calculator is the premier resource for a comprehensive assessment of perioperative risk [36]. The calculator represents a global assessment of a patient’s risk for all complications in the perioperative period and sub-straties by risk for specic complications.
Due to the stress of surgery, patients with outstanding medical conditions should be evaluated before planning surgery and optimized prior to operating. Conditions of the heart, lungs, and liver as well as all concurrent medical issues should be investigated and considered when weighing the risks and benets of proceeding with a repair.
When assessing a patient’s cardiac readiness for surgery, we recommend assess­ment using the American College of Cardiology/American Heart Association guide­lines on perioperative cardiovascular evaluation [37] as well as the multifactorial index of cardiac risk [38]. Patients with pulmonary comorbidities who require small abdominal wall or groin hernia repair should be managed using monitored anes­thetic care if possible to avoid the respiratory strain of general anesthesia and venti­lation. Larger hernias in this population also warrant attention to the effects of
9 Patient Comorbidities Complicating aHernia Repair
restoration following the loss of domain because the reduction of hernia content into the abdominal cavity will create signicant pulmonary changes in peak airway pres­sures and oxygenation. To successfully manage these patients, new studies have described and demonstrated the efcacy of a volume transposition technique [39] in which hernia repair is achieved with mesh that has been sized according to the cal­culated hernia volume. This avoids any increases in the intraabdominal pressure and may reduce the risk of recurrence.
Finally, all pathologies that predispose patients to increased intraabdominal pres­sure should be optimized preoperatively because these pathologies put patients at risk for increased herniagenicity as well as postoperative recurrence. Such condi­tions include chronic constipation, chronic cough, and obstructive uropathies.
115
Preoperative Workup
Laboratory Studies
The laboratory studies that will be useful when planning for a hernia repair are dened by the specics of the patient in question. Based on comorbidities, the type of anesthesia, and the type of repair, different studies must be obtained to optimize and clear the patient for surgery. To this end, the studies we recommend have been discussed alongside the condition that they are aimed to assess. In general, we rec­ommend obtaining a complete blood count, basic metabolic panel, coagulation panel, serum albumin, hemoglobin A1c, and cotinine if the patient is a smoker. In addition to laboratory studies, we wish to emphasize evaluation through imaging studies.
Imaging
While simple hernia may be diagnosed and managed based on physical examination alone, imaging can be an invaluable if not mandatory part of preoperative planning in complex hernias.
Ultrasound can be a helpful adjunct in the detection and management of hernias, particularly those in the groin [40]. Ultrasound had the benet of being inexpensive, noninvasive, and easily performed in the clinic. Ultrasound has achieved particular utility in the detection of occult inguinal hernia as a cause of groin pain. Due to the real-time nature of ultrasound, physicians can image as part of the physical exam and are able to correlate exam ndings and maneuvers, such as Valsalva, with ultra­sound imaging [41].
With more complicated hernias, both inguinal and otherwise, CT is an invalu­able imaging modality for herniography [42], being both relatively inexpensive and nonoperator dependent. CT not only yields information regarding the abdom­inal wall but also provides insight into a patient’s intraabdominal condition. CT scan can be used to assess hernia contents, for example, in the acute setting of
116
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
D. T. K. Huynh and O. M. Ghanem
small bowel obstruction when attempting to determine if the nidus of obstruction is within the hernia sac or due to intraabdominal adhesions. Certain consider­ations should be made when interpreting a CT before hernia repair. First and foremost, the imaging should be assessed in its entirety to identify all defects and their locations so that the most efcient operation can be planned with regard to approach and technique. This identication is best guided by comparison with the physical exam, which should always guide the assessment of hernia. Once the defects have been identied, they should be characterized by answering the fol­lowing questions: What is the size of the defect? Can the defect be primarily closed? What planes have been violated and does this corroborate with data from previous operations? What is the optimal location for mesh placement? How robust is the abdominal wall, and is component separation necessary or even pos­sible? When considering recurrent hernias, one must also assess the position of any old mesh and formulate a strategy for safe explant if needed. Old mesh should be assessed for long-term mesh-related complications, such as shrinkage and adhesions, and these imaging ndings should be compared with the history and physical exam [43].
Perioperative Considerations
Anticoagulation
Anticoagulants are a powerful class of medication that when used appropriately in the surgical setting provide signicant benets to morbidity and mortality but which by denition increase the risk of uncontrolled bleeding: the classic surgical complication. When deciding on whether and when to continue anticoagulation, it is vital to understand what the medication is treating. Ultimately, there is no hard and fast rule to dictate when to maintain and when to discontinue anticoagulation. When in the elective setting, these decisions should be discussed with the cardiol­ogy, medicine, and vascular specialists who are responsible for prescribing these medications, and there should be consensus on whether to stop or bridge these medications. In the emergent setting, we recommend reversal of the agent if pos­sible while ensuring that considerations are made to restart the medication at the appropriate time postoperatively.
Venous Thromboembolism Prophylaxis
Venous thromboembolism is a common perioperative complication in hernia repair. As the complexity and size of the hernia repair increase, so does the period of intra­and postoperative immobility and thus the risk of a venous thromboembolic event. Thus, we recommend adherence to the CHEST guidelines [44] for antithrombotic therapy. These include either low-molecular-weight heparin or low-dose unfraction­ated heparin in addition to mechanical prophylaxis.
9 Patient Comorbidities Complicating aHernia Repair
117
Infection Prophylaxis andControl
A signicant part of hernia repair optimization does involve infection prophylaxis and control. This segment will discuss the different aspects in this regard including antiseptic rinsing, hair removal, skin preparation, antibiotic prophylaxis, as well as MRSA testing.
Preoperative rinses or showering is a controversial subject that has shown vary­ing benet in previous studies. A Cochrane review evaluated the effectiveness of preoperative rinses with antiseptic agents such as chlorhexidine or betadine versus the use of normal soap and found no benet in reducing surgical site infection [45]. However, many of the existing studies available for review have been underpowered and retrospective in a heterogeneous population. Additionally, this evaluation places all antiseptic use in one arm with no consistent protocol with which to compare. With this in mind, we recommend the protocol described in a 2015 study by Edmiston et al. This protocol involves a preoperative minimum of at least two sequential showers using 118 mL of aqueous chlorhexidine gluconate 4% per shower with a 1-min pause after application and before rinsing [46]. This optimizes the antiseptic concentration to best eliminate gram-positive and gram-negative ora prior to surgical intervention.
Hair removal is another intervention in which the evidence has shifted over time. In 1999, the CDC strongly recommended against the removal of hair prior to surgery [47]. However, a 2011 Cochrane review involving 14 randomized trials found no dif- ference in the rate of surgical site infection in patients who had hair preoperatively removed versus those who did not. Moreover, the review concluded that electric clip­pers used to remove hair were associated with a lower rate of surgical site infection than razors [48], a nding that has been recapitulated in other meta-analyses [49]. On the other hand, the National Institute for Health and Clinical Excellence recommen­dations suggested that hair may serve as a nidus for infection and thus recommend that the mode of hair removal should minimize skin trauma [50]. In keeping with these ndings, we recommend the use of either clippers or depilatory cream prior to surgery when it is necessary to gain adequate vision or access to the operative site.
When selecting surgical prep solutions, we recommend chlorhexidine versus povidone-iodine in the clean and clean-contaminated setting of hernia repair surgery [51]. Further, and because alcohol appears to be the operative agent in these solu- tions, alcohol-based preps such as DuraPrep comparable outcomes [52].
The discussion on preoperative antibiotics can rst be divided into the settings of inguinal versus ventral hernias. In inguinal hernias, the discussion can be further delineated by approach. In a double-blinded comparison of antibiotics versus pla­cebo in open inguinal hernias repaired with a mesh plug, antibiotics signicantly reduced the rate of surgical site infection [53] with β-lactam/β-lactamase antibiotics as the most effective agent followed by rst-generation cephalosporins [54]. Conversely, in open groin hernia not restricted to the mesh plug technique, a recent meta-analysis showed no difference in outcomes when preoperative antibiotics were utilized [55]. When considering a laparoscopic approach, studies have similarly
®
and ChloraPrep® can be used with
118
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
D. T. K. Huynh and O. M. Ghanem
shown no benet for antibiotics preoperatively [56]. Nevertheless, our practice still uses prophylactic antibiotics prior to both open and laparoscopic inguinal hernia repair.
The evidence for antibiotics in ventral hernia repair paints a different picture, particularly in incisional hernia. The evidence currently suggests that the rate of wound infection is higher in incisional hernia repair than in other cases similarly classied as clean. As such, the evidence shows a clear benet for the use of systemic antibiotics when performing incisional hernia repair [57]. In keeping with the evi­dence, we recommend following Surgical Care Improvement Project measures, with the administration of preoperative antibiotics within 60min of the surgical start time.
The prophylaxis of methicillin-resistant Staphylococcus aureus (MRSA) is a con­troversial topic. A 2015 study in the Journal of the American College of Surgeons showed that a history of MRSA infection, even those isolated away from the abdom­inal wall, increases the risk of MRSA surgical site infection in ventral hernia repair within the rst 30days postoperatively [58]. However, a similar study published in Hernia Journal in 2016 contradicted these ndings, showing that a history of MRSA infection had no impact on surgical site infection [59]. Both studies were limited as they were retrospective single institution studies; however, when taken together, they appeared to suggest that it was more effective to identify and treat higher risk patients and move away from long-term suppressive antibiotics.
A 2017 discussion post on the International Hernia Collaboration© Facebook group page showed three main strategies for managing MRSA among hernia sur­geons. The rst, in accordance with the 2015 Journal of the American College of Surgeons study, does not test for MRSA at all. The second selectively tests high-risk patients preoperatively using nasal swabs to determine if treatment is necessary, with a high risk being dened as having a personal history of MRSA infection, health care workers, or a history of SSI.The third protocol tested for MRSA with nasal swabs in all patients and treated them accordingly, a strategy that we recommend.
If MRSA testing is positive, we recommend the treatment protocol described by Bode etal., which is comprised of nasal mupirocin twice per day for 5days preop­eratively and daily chlorhexidine showers for 5days [
60]. This protocol was shown
to signicantly decrease the rate of surgical site infection. In addition to this proto­col, we administer cefazolin and vancomycin in the immediate preoperative period to treat both methicillin-sensitive Staphylococcus aureus and MRSA.However, a positive MRSA culture from the wound in proximity or overlying a hernia (stula, infected mesh, etc.) mandates, in addition to the above measures, prolonged (up to a year) suppressive postoperative doxycycline therapy.
Postoperative Considerations
The postoperative optimization is achieved through the enhanced recovery after sur­gery pathway protocol aims to reduce the metabolic, neuroendocrine, and inam­matory impact of surgery to minimize morbidity and length of stay postoperatively
9 Patient Comorbidities Complicating aHernia Repair
119
[61]. This pathway relies on several key principles to accomplish this goal: the maintenance of physiologic function, the reduction of intraoperative stress, the min­imization of postoperative pain, the optimization of mobilization after surgery, and early postoperative enteral nutrition. In application, this involves a preoperative dis­cussion of the hospital course and planned interventions for recovery with the patient to maintain expectations and maximize their participation in their care. In the immediate preoperative period, pain medication and alvimopan should be started to reduce surgical stress and promote postoperative motility, respectively. This leads into the postoperative protocol, which emphasizes an early transition to enteral feeding, early ambulation, incentive spirometry, and the minimal use of narcotics.
Compared to other areas of gastrointestinal surgery, such as colorectal surgery, hernia surgery has lagged behind in implementing enhanced recovery pathways. The rst group to report a protocolized pathway was Novitsky etal. [62], who described an enhanced recovery pathway that we currently follow. These pathways have been validated through numerous metrics and have demonstrated a more rapid advancement of diet and decreased time to return of gastrointestinal function with a signicant cumulative reduction in the length of stay and decreased rate of readmis­sion [63]. These ndings have been recapitulated by many labs, all demonstrating similar benets as well as reductions in reported pain [64] and opiate usage [65].
Conclusion
To best prepare for a hernia, the surgeon must orchestrate a host of interventions
that come together to give the patient the best chance of a good outcome. This
begins with a proper history and physical and the proper use of laboratory studies
and imaging. These tools enable the surgeon to determine the specic preopera-
tive interventions that will benet these patients. Interventions such as optimiz-
ing nutritional status, encouraging smoking cessation, and promoting good
glycemic control provide the patient with a benet that is greater than the sum of
each individual intervention. When combined, this preoperative optimization
enables the surgeon to perform a superior operation and allows the patient to
achieve a superior recovery, thereby decreasing the risks of complications, mor-
bidity, and mortality following hernia repair. The literature guiding these inter-
ventions is constantly in ux; however, we have offered recommendations that
we employ in our own practices and that we believe best embody currently avail-
able evidence.
References
1. Sørensen LT.Wound healing and infection in surgery: the pathophysiological impact of smok-
ing, smoking cessation, and nicotine replacement therapy: a systematic review. Ann Surg. 2012;255(6):1069–79.
2. Sørensen LT, Toft BG, Rygaard J, Ladelund S, Paddon M, James T, etal. Effect of smoking,
smoking cessation, and nicotine patch on wound dimension, vitamin C, and systemic markers of collagen metabolism. Surgery. 2010;148(5):982–90.
120
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
D. T. K. Huynh and O. M. Ghanem
3. Sorensen LT, Karlsmark T, Gottrup F. Abstinence from smoking reduces incisional wound
infection: a randomized controlled trial. Ann Surg. 2003;238(1):1–5.
4. Fischer JP, Wink JD, Nelson JA, Kovach SJ.Among 1,706 cases of abdominal wall recon-
struction, what factors inuence the occurrence of major operative complications? Surgery. 2014;155(2):311–9.
5. Bluman LG, Mosca L, Newman N, Simon DG.Preoperative smoking habits and postoperative
pulmonary complications. Chest. 1998;113(4):883–9.
6. Landin M, Kubasiak JC, Schimpke S, Poirier J, Myers JA, Millikan KW, Luu MB.The effect
of tobacco use on outcomes of laparoscopic and open inguinal hernia repairs: a review of the NSQIP dataset. Surg Endosc. 2017;31(2):917–21.
7. Lovecchio F, Farmer R, Souza J, Khavanin N, Dumanian GA, Kim JY.Risk factors for 30-day
readmission in patients undergoing ventral hernia repair. Surgery. 2014;155(4):702–10.
8. Nelson JA, Fischer J, Chung CC, Wink J, Wes A, Serletti JM, Kovach S.Readmission fol-
lowing ventral hernia repair: a model derived from the ACS-NSQIP datasets. Hernia. 2015;19(1):125–33.
9. Huerta S, Patel PM, Mokdad AA, Chang J. Predictors of inguinodynia, recurrence,
and metachronous hernias after inguinal herniorrhaphy in veteran patients. Am J Surg. 2016;212(3):391–8.
10. Sørensen LT, Hemmingsen UB, Kirkeby LT, Kallehave F, Jørgensen LN. Smoking is a risk
factor for incisional hernia. Arch Surg. 2005;140(2):119–23.
11. Lindström D, Azodi OS, Wladis A, Tønnesen H, Linder S, Nåsell H, etal. Effects of a peri-
operative smoking cessation intervention on postoperative complications: a randomized trial. Ann Surg. 2008;248(5):739–45.
12. Novitsky YW, Orenstein SB.Effect of patient and hospital characteristics on outcomes of elec-
tive ventral hernia repair in the United States. Hernia. 2013;17(5):639–45.
13. Heniford BT, Park A, Ramshaw BJ, Voeller G.Laparoscopic repair of ventral hernias: nine
years’ experience with 850 consecutive hernias. Ann Surg. 2003;238(3):391–9.
14. Sauerland S, Korenkov M, Kleinen T, Arndt M, Paul A.Obesity is a risk factor for recurrence
after incisional hernia repair. Hernia. 2004;8(1):42–6.
15. Pernar LI, Pernar CH, Dieffenbach BV, Brooks DC, Smink DS, Tavakkoli A.What is the BMI
threshold for open ventral hernia repair? Surg Endosc. 2017;31(3):1311–7.
16. Froylich D, Segal M, Weinstein A, Hatib K, Shiloni E, Hazzan D.Laparoscopic versus open
ventral hernia repair in obese patients: a long-term follow-up. Surg Endosc. 2016;30(2):670–5.
17. Tsereteli Z, Pryor BA, Heniford BT, Park A, Voeller G, Ramshaw BJ.Laparoscopic ventral
hernia repair (LVHR) in morbidly obese patients. Hernia. 2008;12(3):233–8.
18. Rosen MJ, Aydogdu K, Grafmiller K, Petro CC, Faiman GH, Prabhu A.A multidisciplinary
approach to medical weight loss prior to complex abdominal wall reconstruction: is it feasible? J Gastrointest Surg. 2015;19(8):1399–406.
19. Hellspong G, Gunnarsson U, Dahlstrand U, Sandblom G.Diabetes as a risk factor in patients
undergoing groin hernia surgery. Langenbecks Arch Surg. 2017;402(2):219–25.
20. Won EJ, Lehman EB, Geletzke AK, Tangel MR, Matsushima K, Brunke-Reese D, et al.
Association of postoperative hyperglycemia with outcomes among patients with complex ven­tral hernia repair. JAMA Surg. 2015;150(5):433–40.
21. Petro CC, Posielski NM, Raigani S, Criss CN, Orenstein SB, Novitsky YW. Risk fac-
tors for wound morbidity after open retromuscular (sublay) hernia repair. Surgery. 2015;158(6):1658–68.
22. Shankar DA, Itani KM, O’Brien WJ, Sanchez VM.Factors associated with long-term out-
comes of umbilical hernia repair. JAMA Surg. 2017;152(5):461–6.
23. Liang MK, Holihan JL, Itani K, Alawadi ZM, Gonzalez JRF, Askenasy EP, Ballecer C,
etal. Ventral hernia management: expert consensus guided by systematic review. Ann Surg. 2017;265(1):80–9.
24. Martindale RG, McClave SA, Vanek VW, McCarthy M, Roberts P, Taylor B, etal. Guidelines
for the provision and assessment of nutrition support therapy in the adult critically ill patient: